This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 Jan;35(1):25-33.

doi: 10.1016/0008-8749(78)90123-5.

Immunological reconstitution of T-cell-deprived mice. I. Inability of thymosin to restore spleen cell mitogen and tumor allograft response

F J Primus, L De Martino, R MacDonald, H J Hansen

PMID: 145898
DOI: 10.1016/0008-8749(78)90123-5

Immunological reconstitution of T-cell-deprived mice. I. Inability of thymosin to restore spleen cell mitogen and tumor allograft response

F J Primus et al. Cell Immunol. 1978 Jan.

. 1978 Jan;35(1):25-33.

doi: 10.1016/0008-8749(78)90123-5.

Authors

F J Primus, L De Martino, R MacDonald, H J Hansen

PMID: 145898
DOI: 10.1016/0008-8749(78)90123-5

No abstract available

PubMed Disclaimer

Similar articles

Manifestation and growth of a transplantable osteosarcoma in mice: the effects of thymectomy and thymosin treatment.
Carlsson SR, Stigbrand T, Boquist L, Lundgren E, Winblad B, Larsson SE. Carlsson SR, et al. Clin Orthop Relat Res. 1981 Sep;(159):279-85. Clin Orthop Relat Res. 1981. PMID: 6974629
Thymosin modulation of suppressor function in mice and man.
Serrou B, Rosenfeld C, Caraux J, Thierry C, Cupissol D, Goldstein A. Serrou B, et al. Ann N Y Acad Sci. 1979;332:95-100. doi: 10.1111/j.1749-6632.1979.tb47101.x. Ann N Y Acad Sci. 1979. PMID: 161154
Some endocrine aspects of the thymus gland.
Caso LV. Caso LV. Jpn J Med Sci Biol. 1976 Dec;29(6):289-321. doi: 10.7883/yoken1952.29.289. Jpn J Med Sci Biol. 1976. PMID: 67231 Review.
Thymosin modulation of regulatory T cell function.
Mutchnick MG, Prieto JA, Schaffner JA, Weller FE. Mutchnick MG, et al. Clin Immunol Immunopathol. 1982 Jun;23(3):626-33. doi: 10.1016/0090-1229(82)90325-7. Clin Immunol Immunopathol. 1982. PMID: 6214350 No abstract available.
Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.
Goldstein AL. Goldstein AL. Antibiot Chemother (1971). 1978;24:47-59. doi: 10.1159/000401500. Antibiot Chemother (1971). 1978. PMID: 350140 Review. No abstract available.

See all similar articles

Cited by

Immunomodulating activity of thymosin fraction 5 and thymosin alpha 1 in immunosuppressed mice.
Ohta Y, Sueki K, Yoneyama Y, Tezuka E, Yagi Y. Ohta Y, et al. Cancer Immunol Immunother. 1983;15(2):108-13. doi: 10.1007/BF00199700. Cancer Immunol Immunother. 1983. PMID: 6553511 Free PMC article.
Immunomodulation and therapeutic characterization of thymosin fraction five.
Talmadge JE, Uithoven KA, Lenz BF, Chirigos M. Talmadge JE, et al. Cancer Immunol Immunother. 1984;18(3):185-94. doi: 10.1007/BF00205510. Cancer Immunol Immunother. 1984. PMID: 6239686 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science